Come up with a name for your new list and we'll add to it:
Symic Biomedical raised a round of funding on August 27, 2015. Investors include
National Institutes of Health.
Symic Bio is developing a new category of therapeutics that offer an exciting biological approach to treating disease. While it is clear that cells play an important role in tissue inflammation and re…